数字农科院2.0

Sequential Deletions of Interferon Inhibitors MGF110-9L and MGF505-7R Result in Sterile Immunity against the Eurasia Strain of Africa Swine Fever

文献类型： 外文期刊

作者： Ding, Mingyang;Dang, Wen;Liu, Huanan;Zhang, Keshan;Xu, Fan;Tian, Hong;Huang, Huaguo;Shi, Zhengwang;Sunkang, Yongjie;Qin, Xiaodong;Zhang, Yong;Zheng, Haixue

作者机构：

关键词： ASFV;MGF110-9L;MGF505-7R;attenuation;protective efficacy

期刊名称： JOURNAL OF VIROLOGY

ISSN： 0022-538X

年卷期： 2022 年

页码：

收录情况： SCIE（2022版）

摘要： African swine fever virus (ASFV) causes significant morbidity and mortality in pigs worldwide. The lack of vaccines or therapeutic options warrants urgent further investigation. To this aim, we developed a rationally designed live attenuated ASFV-D110-9L/505-7R mutant based on the highly pathogenic Genotype II ASFV CN/GS/2018 backbone by deleting 2 well-characterized interferon inhibitors MGF110-9L and MGF505-7R. The mutant was slightly attenuated in vitro compared to parental ASFV but highly tolerant to genetic modifications even after 30 successive passages in vitro. Groups of 5 pigs were intramuscularly inoculated with increasing doses of the mutant, ranging from 10(3) to 10(6) hemadsorption units (HAD(50)). Thirty-five days later, all groups were challenged with 10(2) HAD(50) of virulent parental ASFV. All the animals were clinically normal and devoid of clinical signs consistent with ASFV at the period of inoculation. In the virulent challenge, 2 animals from 10(3) HAD(50)-inoculated group and 1 animal from 10(4) HAD(50)-inoculated group were unprotected with severe postmortem and histological lesions. The rest of animals survived and manifested with relatively normal clinical appearance accompanied by tangible histological improvements in the extent of tissue damage. Meanwhile, antibody response, as represented by p30-specific antibody titers was positively correlated to protective efficacy, potentializing its usage as an indicator of protection. Moreover, compared to 1 dose, 2 doses provided additional protection, proving that 2 doses were better than 1 dose. The sufficiency in effectiveness supports the claim that our attenuated mutant may be a viable vaccine option with which to fight ASF. IMPORTANCE African swine fever virus (ASFV) is a causative agent of acute viral hemorrhagic disease of domestic swine which is associated with significant economic losses in the pig industry. The lack of vaccines or treatment options requires urgent further investigation. ASFV MGF110-9L and MGF505-7R, 2 well-characterized interferon inhibitors, were associated with viral virulence, host range, and immune modulation. In this study, a recombinant two-gene deletion ASFV mutant with deletion of MGF110-9L and MGF5057R was constructed. The result showed that the mutant was safe, and also highly resistant to genetic modification even after 30 successive passages. High doses of our mutant (10(5) and 10(6) HAD(50)) provided sterile immunity and complete protection in a virulent challenge. Two doses were superior to 1 dose and provided additional protection. This study develops a new ASFV-specific live attenuated vaccine and may be a viable vaccine option against ASF.

分类号：

  • 相关文献

[1]Development of a new effective African swine fever virus vaccine candidate by deletion of the H240R and MGF505-7R genes results in protective immunity against the Eurasia strain. Li, Jiangnan,Song, Jie,Zhou, Shijun,Li, Shuai,Liu, Jia,Li, Tingting,Zhang, Zhaoxia,Zhang, Xianfeng,He, Xijun,Chen, Weiye,Zheng, Jun,Zhao, Dongming,Bu, Zhigao,Huang, Li,Weng, Changjiang. 2023

[2]Combinational Deletions of MGF360-9L and MGF505-7R Attenuated Highly Virulent African Swine Fever Virus and Conferred Protection against Homologous Challenge. Ding, Mingyang,Dang, Wen,Liu, Huanan,Xu, Fan,Huang, Huaguo,Sunkang, Yongjie,Li, Tao,Pei, Jingjing,Liu, Xiangtao,Zhang, Yong,Zheng, Haixue. 2022

[3]The Deletion of the MGF360-10L/505-7R Genes of African Swine Fever Virus Results in High Attenuation but No Protection Against Homologous Challenge in Pigs. Linlin Zheng,Zilong Yan,Xiaolan Qi,Jingjing Ren,Zhao Ma,Huanan Liu,Zhao Zhang,Dan Li,Jingjing Pei,Shuqi Xiao,Tao Feng,Xinglong Wang,Haixue Zheng. 2025

[4]ASFV解旋酶D1133L蛋白表达和抗体检测方法的建立及初步应用. 侯景,申超超,张大俊,杨博,史喜绢,张婷,杨泽晓,张克山,郑海学,李丹,党文,刘湘涛. 2021

[5]非洲猪瘟病毒多基因家族MGF360-13L基因功能的初步研究. 陈达年,马旭升,代军飞,汪洋,李茜,白衡,毛甜甜,刘永生,丁龙,陈昊翰,陈思言,饶宇飞,贾宁,张杰,郑海学,刘湘涛. 2022

[6]非洲猪瘟病毒E184L蛋白的原核表达及单克隆抗体的制备. 李雪雯,李婷婷,李长尧,焦爽,郑君,荣俊,翁长江. 2023

[7]Deletions of MGF110-9L and MGF360-9L from African swine fever virus are highly attenuated in swine and confer protection against homologous challenge. Dan Li,Jingjing Ren,Guoqiang Zhu,Panxue Wu,Wenping Yang,Yi Ru,Tao Feng,Huanan Liu,Jing Zhang,Jiangling Peng,Hong Tian,Xiangtao Liu,Haixue Zheng. 2023

[8]Protective efficacy of pVAX-RON5p against acute and chronic infections of Toxoplasma gondii in BALB/c mice. Zhao, Yu,Li, Zhong-Yuan,Chen, Jia,Liu, Shan-Shan,Zhu, Xing-Quan,Zhou, Dong-Hui,Zhao, Yu,Sun, Xiao-Lin,Li, Zhong-Yuan,Liu, Shan-Shan,Zhu, Xing-Quan.

[9]Deletion of the BAC sequences from recombinant meq-null Marek's disease (MD) virus increases immunosuppression while maintaining protective efficacy against MD. Su, S.,Cui, N.,Sun, P.,Cui, Z.,Li, J.,Li, H.,Li, Y..

[10]Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice. Bei, Weicheng,Fu, Shulin,Ou, Jiwen,Tan, Chen,Chen, Huanchun,Bei, Weicheng,Zhang, Minmin,Liu, Jinlin. 2012

[11]Development of a live attenuated vaccine candidate against duck Tembusu viral disease. Li, Guoxin,Gao, Xuyuan,Xiao, Yali,Liu, Shaoqiong,Peng, Shan,Li, Xuesong,Shi, Ying,Zhang, Yuee,Yu, Lei,Wu, Xiaogang,Yan, Pixi,Yan, Liping,Teng, Qiaoyang,Tong, Guangzhi,Li, Zejun. 2014

[12]A safe and molecular-tagged Brucella canis ghosts confer protection against virulent challenge in mice. Qian, Jing,Bu, Zhaoyang,Lang, Xulong,Wang, Xinglong,Qian, Jing,Qian, Jing,Yan, Guangmou,Yang, Yanling,Wang, Xiuran.

[13]Expression of truncated Babesia microti apical membrane protein 1 and rhoptry neck protein 2 and evaluation of their protective efficacy. Wang, Guanbo,Efstratiou, Artemis,Moumouni, Paul Franck Adjou,Liu, Mingming,Jirapattharasate, Charoonluk,Guo, Huanping,Gao, Yang,Suzuki, Hiroshi,Igarashi, Ikuo,Xuan, Xuenan,Cao, Shinuo,Zhou, Mo.

[14]Attenuation of an original US porcine epidemic diarrhea virus strain PC22A via serial cell culture passage. Lin, Chun-Ming,Hou, Yixuan,Gao, Xiang,Liu, Xinsheng,Zheng, Lanlan,Saif, Linda J.,Wang, Qiuhong,Marthaler, Douglas G.,Marthaler, Douglas G.,Liu, Xinsheng,Zheng, Lanlan.

[15]Complete genome comparison of duck hepatitis virus type 1 parental and attenuated strains. Wang, Yong,Li, Chuanfeng,Chen, Zongyan,Li, Gang,Wang, Yong,Xu, Binrui,Li, Gang.

[16]Protective efficacy of a high-growth reassortant swine H3N2 inactivated vaccine constructed by reverse genetic manipulation. Wen, Feng,Ma, Ji-Hong,Yu, Hai,Yang, Fu-Ru,Huang, Meng,Zhou, Yan-Jun,Li, Ze-Jun,Tong, Guang-Zhi.

[17]Changes in VP3 and VP5 genes during the attenuation of the very virulent infectious bursal disease virus strain Gx isolated in China. Wang, Xiaomei,Zhang, Houshuang,Gao, Honglei,Fu, Chaoyang,Gao, Yulong,Ju, Yulin. 2007

[18]Molecular characterization of a Chinese vaccine strain of transmissible gastroenteritis virus: mutations that may contribute to attenuation. Wang, Chengbao,Chen, Jianfei,Shi, Hongyan,Qiu, Huaji,Xue, Fei,Liu, Changming,Zhu, Yuanmao,Liu, Shengwang,Feng, Li,Almazan, Fernando,Enjuanes, Luis. 2010

[19]Mutations in the genome of the highly pathogenic porcine reproductive and respiratory syndrome virus potentially related to attenuation. Leng, Xue,Li, Zhenguang,Wang, Fengxue,Wang, Wei,Zhang, Xiuhua,Wu, Hua,Xia, Mingqi,Li, Xiyu,Wu, Hua.

[20]Recombinant duck enteritis viruses expressing major structural proteins of the infectious bronchitis virus provide protection against infectious bronchitis in chickens. Li, Huixin,Wang, Yulong,Han, Zongxi,Wang, Yu,Liang, Shulin,Jiang, Lu,Kong, Xiangang,Liu, Shengwang,Wang, Yulong,Hu, Yonghao.

作者其他论文 更多>>